Participant Flow: Tegoprazan vs Esomeprazole Triple Therapy for H. Helicobacter pylori infection (IMAGE)
Caption
*Safety set: all participants who received treatment at least once after randomization. †Full analysis set: all randomized participants who received at least one dose of the study drug and completed a post-baseline efficacy assessment. ‡Per-protocol set: a subset of the full analysis set with no significant protocol deviations impacting efficacy evaluation. §Detailed reasons for major protocol deviations affecting efficacy assessment were provided in the Supplementary Table 3,https://links.lww.com/CM9/C616.
Credit
Dr. Liya Zhou, Peking University Third Hospital, China Image source link: http://doi.org/10.1097/CM9.0000000000003780
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND